BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Stimulator, Electrical, Implanted, For Parkinsonian Symptoms

    PMA: P150031 · Supplement: S080 · Decision Dec 23, 2024
    View on FDA
    Classifications
    1
    FEI Numbers
    31
    Registration Numbers
    31

    Basic Information

    Device Name
    Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
    Trade Name
    Vercise Genus Deep Brain Stimulation System
    PMA Number
    P150031
    Supplement Number
    S080
    Device Class
    FDA Class 3
    Product Code
    NHL
    Generic Name
    Stimulator, electrical, implanted, for parkinsonian symptoms
    Medical Specialty
    Unknown
    Advisory Committee
    Neurology
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    December 23, 2024
    Date Received
    December 5, 2024
    Supplement Type
    Special (Immediate Track)
    Supplement Reason
    Labeling Change - Indications/instructions/shelf life/tradename
    Expedited Review
    N

    Advisory Committee Statement

    The supplement was submitted as a part of an advisory issued in August 2024. The labeling change is to add the following warning to the ''Implanting the IPG'' Section (Step 15) of the Surgical Implant Manual:''Submuscular implant in the pectoral region (i.e. subpectoral) may expose the Vercise Genus rechargeable IPG to frequent muscle tension forces which may cause component damage (feedthrough wire(s)) resulting in device malfunction that could lead to adverse events including explant of the IPG”

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NHL Stimulator, Electrical, Implanted, For Parkinsonian Symptoms